Faecal microbiota transplantation for patients with diabetes type 1 and severe gastrointestinal neuropathy (FADIGAS): a randomised, double-blinded, placebo-controlled trialResearch in context

Summary: Background: Diabetic gastroenteropathy is associated with nausea, vomiting, bloating, pain, constipation, and diarrhoea. Current therapies are scarce. We tested faecal microbiota transplantation (FMT) for patients with type 1 diabetes and gastroenteropathy. Methods: In a randomised, double...

Полное описание

Библиографические подробности

Главные авторы:	Katrine Lundby Høyer, Simon Mark Dahl Baunwall, Ditte Smed Kornum, Mette Winther Klinge, Asbjørn Mohr Drewes, Knud Bonnet Yderstræde, Louise Bruun Thingholm, Martin Steen Mortensen, Susan Mikkelsen, Christian Erikstrup, Christian Lodberg Hvas, Klaus Krogh
Формат:	Artigo
Язык:	Inglês
Опубликовано:	Elsevier 2025-01-01
Серии:	EClinicalMedicine
Предметы:	Diabetes Fecal microbiota transplantations Diarrhea Randomized controlled trial
Online-ссылка:	http://www.sciencedirect.com/science/article/pii/S2589537024005790
Метки:	Добавить метку Нет меток, Требуется 1-ая метка записи!